Provention Bio Inc.

NASDAQ: PRVB · Real-Time Price · USD
24.98
0.00 (0.00%)
At close: Apr 26, 2023, 10:00 PM

Provention Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
10.81M 756K 746K 580K 717K 678K n/a n/a
Cost of Revenue
512K n/a n/a n/a n/a n/a n/a n/a
Gross Profit
10.3M 756K 746K 580K 717K 678K n/a n/a
Operating Income
-40.17M -29.08M -29.83M -29.08M -25.83M -27.08M -30.17M -32.47M
Interest Income
1.34M 700K 146K 57K 32K 55K 31K 28K
Pretax Income
-39.61M -28.63M -29.69M -29.02M -25.83M -27.02M -30.14M -32.44M
Net Income
-33.28M -28.19M -29.54M -21.97M -25.83M -27.02M -29.14M -32.44M
Selling & General & Admin
24.31M 13.49M 14M 12.31M 11.33M 10.03M 13.21M 12.78M
Research & Development
25.53M 16.34M 16.58M 17.36M 15.25M 17.72M 16.97M 19.69M
Other Expenses
627K n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
50.47M 29.83M 30.58M 29.66M 26.58M 27.75M 30.17M 32.47M
Interest Expense
782K 255K 146K n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
50.98M 29.83M 30.58M 29.66M 26.58M 27.75M 30.17M 32.47M
Income Tax Expense
-6.34M -445K -146K -7.06M 32K 55K -1M 28K
Shares Outstanding (Basic)
74.72M 83.12M 64.72M 63.4M 63.38M 63.38M 63.38M 62.26M
Shares Outstanding (Diluted)
74.72M 83.12M 64.72M 63.4M 63.38M 63.38M 63.38M 62.26M
EPS (Basic)
-0.45 -0.34 -0.46 -0.35 -0.41 -0.43 -0.46 -0.52
EPS (Diluted)
-0.45 -0.34 -0.46 -0.35 -0.41 -0.43 -0.46 -0.52
EBITDA
-38.02M -28.23M -29.7M -28.94M -25.69M -27.08M -30.17M -32.47M
EBIT
-38.83M -28.38M -29.54M -29.08M -25.83M -27.08M -30.17M -32.47M
Depreciation & Amortization
2.15M 844K 136K 137K 137K 96K 81K 73K